Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Document type

Article

Version

Published version

Publication date

Publication license

cc by (c) Mesia et al., 2021
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/176191

SEOM clinical guidelines for the treatment of head and neck cancer (2020)

Journal Title

Director/Tutor

Journal ISSN

Volume Title

Abstract

Head and neck cancers (HNC) are defined as malignant tumours located in the upper aerodigestive tract and represents 5% of oncologic cases in adults in Spain. More than 90% of these tumours have squamous histology. In an effort to incorporate evidence obtained since 2017 publication, the Spanish Society of Medical Oncology (SEOM) presents an update of the squamous cell HNC diagnosis and treatment guideline. Most relevant diagnostic and therapeutic changes from the last guideline have been updated: introduction of sentinel node biopsy in early oral/oropharyngeal cancer treated with surgery, concomitant radiotherapy with weekly cisplatin 40 mg/m2 in the adjuvant setting, new approaches for HPV-related oropharyngeal cancer and new treatments with immune-checkpoint inhibitors in recurrent/metastatic disease.

Citation

Citation

MESÍA NIN, Ricard, et al. SEOM clinical guidelines for the treatment of head and neck cancer (2020). Clinical and Translational Oncology. 2021. [consulted: 15 of August of 2026]. Available at: https://hdl.handle.net/2445/176191

Export metadata

JSON - METS

Share record